2024 Developments in Cardiometabolic Care for the Busy Primary Care PhysicianIndustry Webcast Sponsored by Labcorp; Not for CME/CE Credit

The primary care team – including NP/PAs - is often the first to evaluate and assess chronic conditions and interconnected comorbidities, such as steatotic liver disease, renal disease and type 2 diabetes (T2D) using diagnostic assays. Please join Labcorp to explore the latest therapeutic and diagnostic developments in renal and liver manifestations of metabolic disease, including popular topics such as the use of GLP-1 and dual agonists for weight and metabolic disease management.

This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.

Watch

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 8/20/2024

Expiration Date: 2/22/2025

Topics

Cardiology

Faculty

Kenneth Cusi, MD, FACP, FACE

Faculty

Kenneth Cusi, MD, FACP, FACE

Professor of Medicine, Chief, Division of Endocrinology, Diabetes, and Metabolism, University of Florida, Gainesville, FL

Learn More

Industry Sponsor

Labcorp

Fine Print

Computer System Requirements

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.